MAPT and Alzheimer disease: Pathologically, AD is characterized by the accumulation of tau-enriched neurofibrillary tangles (NFTs) and β-amyloid (Aβ) toxic aggregates in the hippocampus and cerebral cortex of the brain [5], which are the major pathological markers of AD [6,7].